Revelation Biosciences, Inc. (REVBW) Warrants
Each REVBW warrant gives the holder the right to buy 1/201,600 share of Revelation Biosciences, Inc. at $2,318,400 per share, until January 10, 2027. The stock last closed at $3.69, below the strike, so the warrant is out of the money. Revelation Biosciences, Inc. has a market value of about $2.52M. There are 7.28M listed warrants; exercising all of them would add 0.0% to the 683.44K shares outstanding. The company can call the warrants if the stock trades at or above $3,628,800.
Revelation Biosciences, Inc. reports its business to the SEC as “Pharmaceutical Preparations”, with its head office in San Diego, CA; it is incorporated in Delaware. The REVBW warrants were first issued by a SPAC and became Revelation Biosciences, Inc. warrants when the merger closed on January 10, 2022. Its latest SEC filing was on November 13, 2026: current report (investor update), form 8-K. The warrant closed at $0.0021 on November 19, 2026, down 82% from $0.0114 on November 19, 2025. REVB trades at 0.00016% of the strike; it would have to rise about 628,293-fold to reach it.
Why is the strike so large? Revelation Biosciences, Inc. has combined its shares in one or more reverse splits. The strike is quoted per whole share, so it rose each time, and each warrant now buys only 1/201,600 of a share. Exercising one warrant costs $11.50.
Thinly traded: REVBW traded about $152 a day over the last 30 days, and on only 19 of 22 trading days. With so little trading you may not be able to buy or sell near the price shown; use a limit order.
Key terms
- Strike per share
- $2,318,400
- Shares per warrant
- 1/201,600
- Cash to exercise one warrant
- $11.50
- Expiry
- 2027-01-10
- Redemption trigger
- $3,628,800
- Cashless exercise
- allowed
- Break-even stock price
- $2,318,823
From the issuer's S-1/A (2020-08-26).
Redemption risk Low
REVB closed at or above $3,628,800 on 0 of the last 30 trading days. The company can call the warrants once it reaches 20, so 20 more days above the trigger would be enough.
- Trigger price
- $3,628,800
- Last close
- $3.69 (0% of trigger)
- Days at or above, last 30
- 0 (needs 20)
The usual rule: 20 closes at or above the trigger within 30 trading days, then 30 days' notice. Some companies use a different test; check the warrant agreement. Counted from daily closes up to 2026-11-20. Follow REVBW to get an email when it gets close.
Exercise calculator
Each warrant buys 1/201,600 share at $2,318,400. Before expiry a warrant usually sells for more than its exercise value, because it still has time left. Fees and taxes are not included. Arithmetic, not investment advice.
Company and stock
- Company
- Revelation Biosciences, Inc.
- Underlying stock
- REVB
- Share price
- $3.69
- Market cap
- $2.52M
- Shares outstanding
- 683.44K
- 12-month range
- $3.20 – $26.57
- 12-month change
- +7%
- Value of all listed warrants
- $15.28K (0.6% of market cap)
- Industry
- Pharmaceutical Preparations
- Head office
- San Diego, CA
- Incorporated in
- Delaware
Market cap is the last share price times shares outstanding (as of 2026-11-02). Industry and head office are as the company reports them to the SEC. All SEC filings for this company.
Model value Pro · free for now
- Last price
- $0.0021
- Stock volatility, measured
- 217% (three days make up most of it)
- Volatility we use
- 50% · 80% · 100%
- Volatility the price implies
- none: the warrant costs more than the shares it buys
- Redemption trigger
- $3,628,800
- Method
- day-by-day tree with the redemption trigger
The estimate uses a volatility below the one measured, because measured volatility overstates what the market pays for. Not investment advice.
Dilution
- Shares outstanding
- 683.44K
- Listed warrants
- 7.28M
- Dilution if all exercised
- 0.0%
Warrant count from the notes to the company's financial statements. Confidence: medium.
Filings
- 8-KCurrent report: investor update
- 8-KCurrent report: results
- 10-QQuarterly report
- 8-KCurrent report: directors or officers changed
- 8-KCurrent report: results
- 10-QQuarterly report
- 8-KCurrent report: material agreement; holders' rights changed; charter or bylaws changed; investor update Key
- 8-KCurrent report: directors or officers changed; charter or bylaws changed; shareholder vote results
- 8-KCurrent report: other events
- DEF 14AProxy for a shareholder vote
The company's latest SEC filings, checked every night. Insider trades and routine SEC paperwork are left out. All SEC filings for this company.
Events
- Reverse split 1:4
- Reverse split 1:3
- Reverse split 1:16
- Reverse split 1:35
- Merger closed; the warrants became warrants of the combined company
- Terms source: S-1/A
- Reverse split 2024-01 1:30
Questions about REVBW
When does the REVBW warrant expire?
REVBW expires on January 10, 2027.
What is the strike price of REVBW?
$2,318,400 per share; each warrant converts into 1/201,600 share, so exercising one warrant costs $11.50.
Can Revelation Biosciences, Inc. redeem the REVBW warrants early?
Yes. The company can call them if the share price reaches $3,628,800 for the required period (usually 20 of 30 trading days).
How many REVBW warrants are outstanding?
7.28M listed warrants, equal to 0.0% dilution if all are exercised.
Related warrants
Get an email when alerts open
Follow REVBW with the button at the top to get its alerts. Alerts are coming soon; leave your email and we will tell you when they open.

